1
2
van der Meulen, Matthijs, Bromberg, Jacoline E C, Nijland, Marcel, Visser, Otto, Doorduijn, Jeanette K, Dinmohamed, Avinash G
Veröffentlicht in: van der Meulen , M , Bromberg , J E C , Nijland , M , Visser , O , Doorduijn , J K & Dinmohamed , A G 2021 , ' Primary therapy and survival in patients over 70 years old with primary central nervous system lymphoma : a contemporary, nationwide, population-based study in the Netherlands ' , Haematologica , vol. 106 , no. 2 , pp. 597-600 . https://doi.org/10.3324/haematol.2020.247536;
2021
Veröffentlicht in: van der Meulen , M , Bromberg , J E C , Nijland , M , Visser , O , Doorduijn , J K & Dinmohamed , A G 2021 , ' Primary therapy and survival in patients over 70 years old with primary central nervous system lymphoma : a contemporary, nationwide, population-based study in the Netherlands ' , Haematologica , vol. 106 , no. 2 , pp. 597-600 . https://doi.org/10.3324/haematol.2020.247536;
2021
3
van der Meulen, Matthijs, Bromberg, Jacoline E C, Nijland, Marcel, Visser, Otto, Doorduijn, Jeanette K, Dinmohamed, Avinash G
Veröffentlicht in: van der Meulen , M , Bromberg , J E C , Nijland , M , Visser , O , Doorduijn , J K & Dinmohamed , A G 2021 , ' Primary therapy and survival in patients aged over 70-years-old with primary central nervous system lymphoma : a contemporary, nationwide, population-based study in the Netherlands ' , Haematologica , vol. 106 , no. 2 , pp. 597-600 . https://doi.org/10.3324/haematol.2020.247536;
2021
Veröffentlicht in: van der Meulen , M , Bromberg , J E C , Nijland , M , Visser , O , Doorduijn , J K & Dinmohamed , A G 2021 , ' Primary therapy and survival in patients aged over 70-years-old with primary central nervous system lymphoma : a contemporary, nationwide, population-based study in the Netherlands ' , Haematologica , vol. 106 , no. 2 , pp. 597-600 . https://doi.org/10.3324/haematol.2020.247536;
2021
4
Bult, Johanna A A, Huisman, Francien, Zhong, Yujie, Veltmaat, Nick, Kluiver, Joost, Tonino, Sanne H, Vermaat, Joost S P, Chamuleau, Martine E D, Diepstra, Arjan, van den Berg, Anke, Plattel, Wouter J, Brink, Mirian, Nijland, Marcel
Veröffentlicht in: Bult , J A A , Huisman , F , Zhong , Y , Veltmaat , N , Kluiver , J , Tonino , S H , Vermaat , J S P , Chamuleau , M E D , Diepstra , A , van den Berg , A , Plattel , W J , Brink , M & Nijland , M 2023 , ' A population-based study of transformed marginal zone lymphoma : identifying outcome-related characteristics ' , Blood cancer journal , vol. 13 , 130 . https://doi.org/10.1038/s41408-023-00903-w;
2023
Veröffentlicht in: Bult , J A A , Huisman , F , Zhong , Y , Veltmaat , N , Kluiver , J , Tonino , S H , Vermaat , J S P , Chamuleau , M E D , Diepstra , A , van den Berg , A , Plattel , W J , Brink , M & Nijland , M 2023 , ' A population-based study of transformed marginal zone lymphoma : identifying outcome-related characteristics ' , Blood cancer journal , vol. 13 , 130 . https://doi.org/10.1038/s41408-023-00903-w;
2023
5
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie José, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
6
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie Jose, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
7
Meeuwes, Frederik O, Brink, Mirian, Plattel, Wouter, Van der Poel, Marjolein W M, Kersten, Marie José, Wondergem, Mariëlle, Böhmer, Lara, Woei-A-Jin, F J Sherida H, Visser, Otto, Oostvogels, Rimke, Jansen, Patty M, Neelis, Karen J, Crijns, Anne P G, Daniëls, Laurien A, Snijders, Tjeerd J F, Vermaat, Joost S P, Huls, Gerwin A, Nijland, Marcel
Veröffentlicht in: Meeuwes , F O , Brink , M , Plattel , W , Van der Poel , M W M , Kersten , M J , Wondergem , M , Böhmer , L , Woei-A-Jin , F J S H , Visser , O , Oostvogels , R , Jansen , P M , Neelis , K J , Crijns , A P G , Daniëls , L A , Snijders , T J F , Vermaat , J S P , Huls , G A & Nijland , M 2024 , ' Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands ' , Haematologica , vol. 109 , no. 4 , pp. 1163-1170 . https://doi.org/10.3324/haematol.2023.283174;
2024
Veröffentlicht in: Meeuwes , F O , Brink , M , Plattel , W , Van der Poel , M W M , Kersten , M J , Wondergem , M , Böhmer , L , Woei-A-Jin , F J S H , Visser , O , Oostvogels , R , Jansen , P M , Neelis , K J , Crijns , A P G , Daniëls , L A , Snijders , T J F , Vermaat , J S P , Huls , G A & Nijland , M 2024 , ' Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands ' , Haematologica , vol. 109 , no. 4 , pp. 1163-1170 . https://doi.org/10.3324/haematol.2023.283174;
2024